Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales
Related Posts
Stringer WW. COVID-19 Has Taught Us That Not All COPD Exacerbations are Created Equal. Ann Am Thorac Soc. 2026 Jun 8:aaoag153. doi: 10.1093/annalsats/aaoag153. Epub ahead[...]
Jendzjowsky N, Kuo CS, Reznikov LR, Chen Z, Li P, Prescott S, Liu Y, Seeholzer L, Tschumperlin DJ, Taylor-Clark TE, Rajagopal J, Haber AL, Noël[...]
Olson TE, Lloyd TS, Hamad CD, Chun RF, Wiener J, Golzar A, Mehany J, Shahamatdar S, Kittredge A, Pearce L, Francis KP, Obeidin F, Holly[...]